Adaptive Biotechnologies (ADPT) Intangibles (2018 - 2026)

Adaptive Biotechnologies has disclosed Intangibles across 9 years of filings, most recently posting $1.3 million for Q1 2026.

• Intangibles for Q1 2026 came in at $1.3 million, down 56.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 56.52% YoY), and the FY2025 annual result was $1.7 million, down 91.51% from the prior year.
• Intangibles came in at $1.3 million for Q1 2026 at Adaptive Biotechnologies, down from $1.7 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $20.3 million in Q1 2022 to a low of $1.3 million in Q1 2026.
• The 5-year median for Intangibles is $5.6 million (2023), against an average of $8.8 million.
• Across the five-year window, Intangibles jumped 138.39% in 2022 and sank 91.51% in 2025, its largest moves.
• Adaptive Biotechnologies' Intangibles stood at $20.3 million in 2022, then changed by 0.0% to $20.3 million in 2023, then changed by 0.0% to $20.3 million in 2024, then tumbled by 91.51% to $1.7 million in 2025, then fell by 24.28% to $1.3 million in 2026.
• The last three Intangibles figures came in at $1.3 million (Q1 2026), $1.7 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.